{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:29:17Z","timestamp":1744154957211},"reference-count":36,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Blood donors are often used as proxies for the general population in studies of\n            <jats:italic>Helicobacter pylori<\/jats:italic>\n            epidemiology. Our aim was to test if the age-specific seroprevalence rates among blood donors match with the corresponding rates in a random population sample. This descriptive study was based on sera obtained from 3,502 blood donors representing all Swedish counties and cities. An age-stratified random population sample of 1,030 from Stockholm County served as comparison. Sera were analyzed by an in-house enzyme-linked immunosorbent assay for\n            <jats:italic>H. pylori<\/jats:italic>\n            immunoglobulin G antibodies. In the population sample, we found the expected increase with age in the seroprevalence of\n            <jats:italic>H. pylori<\/jats:italic>\n            infection. This was true also among young blood donors, while the prevalence-by-age curve showed a deflection downward among blood donors who are \u2265 50 years of age. In this age group, the probability of being seropositive was reduced by 73% (95% confidence interval [CI], 63 to 81%) relative to the population sample. Overall, the adjusted odds ratio for\n            <jats:italic>H. pylori<\/jats:italic>\n            seropositivity among blood donors was decreased by 43% (95% CI, 28 to 55%). Thus, it appears that blood donors who are\n            <jats:italic>H. pylori<\/jats:italic>\n            seropositive selectively disappear from the blood donor cohort. We speculate that\n            <jats:italic>H. pylori<\/jats:italic>\n            -seropositive blood donors may tolerate repeated bleedings less well than do noninfected individuals and\/or that the general well-being among those who are infected may be somewhat impaired. Our unexpected observation indicates that blood donors may be less suitable as proxies for the general population in analytic studies of\n            <jats:italic>H. pylori<\/jats:italic>\n            infection and that the underlying cause needs further study.\n          <\/jats:p>","DOI":"10.1128\/jcm.41.9.4038-4042.2003","type":"journal-article","created":{"date-parts":[[2003,9,4]],"date-time":"2003-09-04T18:34:38Z","timestamp":1062700478000},"page":"4038-4042","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Unexpected Decrease with Age of\n            <i>Helicobacter pylori<\/i>\n            Seroprevalence among Swedish Blood Donors"],"prefix":"10.1128","volume":"41","author":[{"given":"M.","family":"So\u0308rberg","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Nyre\u0301n","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Granstro\u0308m","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, MTC, Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.1.219"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1083-4389.2002.00073.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549309008483"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03686.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609036904"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00952-4"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199601000-00009"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00315-7"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.12.1681"},{"key":"e_1_3_2_11_2","first-page":"17","volume":"4","year":"1992","unstructured":"Dixon, M. F., and G. M. Sobala. 1992. Gastritis and duodenitis: histopathological spectrum. Eur. J. Gastroenterol. Hepatol.4(Suppl. 2):17-23.","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27999"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.12.1672"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.2.468-470.1997"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00399.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529008999220"},{"key":"e_1_3_2_18_2","first-page":"1","volume":"61","year":"1994","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1994. Schistosomes, liver flukes and Helicobacter pylori.IARC Monogr. Eval. Carcinog. Risks Hum.61:1-241.","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.9.1349"},{"key":"e_1_3_2_20_2","first-page":"280","volume":"1","year":"1996","unstructured":"Kopanski, Z., E. Golec, B. Witkowska, E. Slowakiewicz, A. Migas-Nirska, and A. Cienciala. 1996. The relationship between the frequency of the appearance of IgG against Helicobacter pylori and the main blood groups among patients with ulcer sickness and stomach cancer. Eur. J. Med. Res.1:280-282.","journal-title":"Eur. J. Med. Res."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909092247"},{"key":"e_1_3_2_22_2","first-page":"263","volume":"90","year":"1998","unstructured":"Martin de Argila, C., D. Boixeda, S. Valdezate, N. Mir, R. Barcena, J. P. Gisbert, A. Garcia Plaza, and R. Canton. 1998. ABO blood groups, rhesus factor and Helicobacter pylori.Rev. Esp. Enferm. Dig.90:263-268.","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01212.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.27.8.1870-1873.1989"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800048366"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70192-1"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.13.1427"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.37"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(98)80124-2"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.6.885-888.2000"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251603"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005990050080"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117725"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199908000-00010"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.3.309"},{"key":"e_1_3_2_36_2","first-page":"712","volume":"32","year":"1997","unstructured":"Wagtmans, M. J., A. M. Witte, D. R. Taylor, I. Biemond, R. A. Veenendaal, H. W. Verspaget, C. B. Lamers, and R. A. van Hogezand. 1997. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand. J. Gastroenterol.32:712-718.","journal-title":"Scand. J. Gastroenterol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410060018004"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.9.4038-4042.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.9.4038-4042.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:25:22Z","timestamp":1646447122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.41.9.4038-4042.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1128\/JCM.41.9.4038-4042.2003"],"URL":"https:\/\/doi.org\/10.1128\/jcm.41.9.4038-4042.2003","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"2003-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-06-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}